AVEANNA HEALTHCARE HOLDINGS INC. Financials Aveanna Healthcare Holdings Inc.
Equities
AVAH
US05356F1057
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.61 USD | -0.38% |
|
-6.79% | -2.61% |
| May. 13 | UBS Adjusts Aveanna Healthcare Price Target to $1.70 From $1.60, Maintains Sell Rating | MT |
| May. 09 | Transcript : Aveanna Healthcare Holdings Inc., Q1 2024 Earnings Call, May 09, 2024 |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,324 | 145 | 511.2 | 502.1 | - | - |
| Enterprise Value (EV) 1 | 2,649 | 1,416 | 511.2 | 1,865 | 1,860 | 1,901 |
| P/E ratio | -10.4 x | -0.22 x | -3.77 x | -21.6 x | -124 x | 39.6 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.79 x | 0.08 x | 0.27 x | 0.25 x | 0.24 x | 0.23 x |
| EV / Revenue | 1.58 x | 0.79 x | 0.27 x | 0.94 x | 0.9 x | 0.88 x |
| EV / EBITDA | 14.4 x | 11 x | 3.67 x | 12.3 x | 11.3 x | 10.4 x |
| EV / FCF | -97 x | -23.4 x | - | 1,865 x | 114 x | 106 x |
| FCF Yield | -1.03% | -4.27% | - | 0.05% | 0.88% | 0.95% |
| Price to Book | 2.08 x | -35.3 x | - | -3.65 x | -3.86 x | -4.7 x |
| Nbr of stocks (in thousands) | 184,164 | 185,918 | 190,733 | 192,379 | - | - |
| Reference price 2 | 7.190 | 0.7800 | 2.680 | 2.610 | 2.610 | 2.610 |
| Announcement Date | 3/28/22 | 3/16/23 | 3/14/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,495 | 1,679 | 1,788 | 1,895 | 1,979 | 2,073 | 2,172 |
| EBITDA 1 | - | 184.2 | 129.3 | 139.2 | 151 | 164.5 | 182 |
| EBIT 1 | - | 163.7 | 108 | 125.4 | 138.4 | 151.6 | 175.7 |
| Operating Margin | - | 9.75% | 6.04% | 6.62% | 7% | 7.31% | 8.09% |
| Earnings before Tax (EBT) 1 | - | -113.6 | -663.8 | -139 | -12.55 | -7.35 | 13.25 |
| Net income 1 | - | -117 | -662 | -134.5 | -23.99 | -6.318 | 13.14 |
| Net margin | - | -6.97% | -37.03% | -7.1% | -1.21% | -0.3% | 0.61% |
| EPS 2 | -8.300 | -0.6900 | -3.570 | -0.7100 | -0.1206 | -0.0210 | 0.0658 |
| Free Cash Flow 1 | - | -27.3 | -60.42 | - | 1 | 16.32 | 18 |
| FCF margin | - | -1.63% | -3.38% | - | 0.05% | 0.79% | 0.83% |
| FCF Conversion (EBITDA) | - | - | - | - | 0.66% | 9.92% | 9.89% |
| FCF Conversion (Net income) | - | - | - | - | - | - | 136.96% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 4/1/21 | 3/28/22 | 3/16/23 | 3/14/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 414.1 | 450.5 | 443 | 443 | 451.1 | 466.4 | 471.9 | 478 | 478.8 | 490.7 | 493.1 | 497.4 | 499.2 | 512.4 | 516.7 |
| EBITDA 1 | 45.84 | 37.95 | 36.97 | 24.75 | 29.66 | 28.48 | 35.86 | 36.19 | 38.66 | 34.88 | 37.05 | 39 | 41.27 | 39.93 | 41.54 |
| EBIT 1 | 40.46 | 32.13 | 30.93 | 19.83 | 25.12 | 24.44 | 32.36 | 33.23 | 35.38 | 31.97 | 33.73 | 36.2 | 38.67 | 36.37 | 38.79 |
| Operating Margin | 9.77% | 7.13% | 6.98% | 4.48% | 5.57% | 5.24% | 6.86% | 6.95% | 7.39% | 6.52% | 6.84% | 7.28% | 7.75% | 7.1% | 7.51% |
| Earnings before Tax (EBT) 1 | -122.1 | 27.93 | -474.2 | 21.63 | -239.1 | -30.43 | 24.79 | -101.8 | -31.6 | - | -6.15 | -5.15 | -3 | -2.25 | -1.55 |
| Net income 1 | -126.2 | 25.33 | -473.9 | 24.3 | -237.8 | -32 | 25.6 | -102.4 | -25.74 | -11.17 | -5.884 | -4.547 | -2.555 | -2.062 | -0.9977 |
| Net margin | -30.48% | 5.62% | -106.98% | 5.48% | -52.71% | -6.86% | 5.42% | -21.42% | -5.37% | -2.28% | -1.19% | -0.91% | -0.51% | -0.4% | -0.19% |
| EPS 2 | -0.6800 | 0.1400 | -2.560 | 0.1300 | -1.280 | -0.1700 | 0.1300 | -0.5400 | -0.1300 | -0.0600 | -0.0268 | -0.0221 | -0.0125 | -0.009720 | -0.006140 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/28/22 | 5/11/22 | 8/10/22 | 11/9/22 | 3/16/23 | 5/11/23 | 8/10/23 | 11/9/23 | 3/14/24 | 5/9/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 1,325 | 1,271 | - | 1,363 | 1,358 | 1,399 |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 7.19 x | 9.829 x | - | 9.021 x | 8.255 x | 7.684 x |
| Free Cash Flow 1 | - | -27.3 | -60.4 | - | 1 | 16.3 | 18 |
| ROE (net income / shareholders' equity) | - | 15.7% | 0.23% | - | - | - | - |
| ROA (Net income/ Total Assets) | - | 3.41% | 0.04% | - | -1.03% | -0.17% | 0.86% |
| Assets 1 | - | -3,432 | -1,844,620 | - | 2,321 | 3,719 | 1,532 |
| Book Value Per Share 2 | - | 3.450 | -0.0200 | - | -0.7200 | -0.6800 | -0.5600 |
| Cash Flow per Share 2 | - | -0.0700 | -0.2600 | 0.1200 | 0.0300 | 0.1400 | 0.2500 |
| Capex 1 | - | 16 | 12 | - | 7.53 | 9.99 | 10.3 |
| Capex / Sales | - | 0.95% | 0.67% | - | 0.38% | 0.48% | 0.47% |
| Announcement Date | 4/1/21 | 3/28/22 | 3/16/23 | 3/14/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
2.61
USD
Average target price
2.64
USD
Spread / Average Target
+1.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.61% | 502M | |
| +25.52% | 88.99B | |
| -24.52% | 74.82B | |
| -0.35% | 25.03B | |
| +4.31% | 17.88B | |
| -14.25% | 16.43B | |
| +2.97% | 15.77B | |
| +79.20% | 13.21B | |
| +70.11% | 13.08B | |
| +40.44% | 12.9B |
- Stock Market
- Equities
- AVAH Stock
- Financials Aveanna Healthcare Holdings Inc.
